Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams

Journal of Pediatric Surgery

Volumn 44, Issue 8, 2009, Pages 1479-1490

  Bondoc, Alexander J ^a   Jafri, Mubeen A ^a   Donnelly, Bryan ^a   Mohanty, Sujit K ^a   McNeal, Monica M ^b   Ward, Richard L ^b   Tiao, Greg M ^a  

^a Department of Pediatric and Thoracic Surgery ^*  (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Biliary atresia; Maternal immunization; Rotateq; Rotavirus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; NUCLEOCAPSID PROTEIN; PROTEIN VP6; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BILE DUCT ATRESIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HEPATOBILIARY DISEASE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VIRUS; LOW DRUG DOSE; MOUSE; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, VIRAL; BILIARY ATRESIA; CAPSID PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MACACA MULATTA; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 67650935178     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.05.034     Document Type: Article

References (46)

1. Mack C.L., and Sokol R.J. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 57 (2005) 87R-94R
2. Landing B.H. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst-the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 6 (1974) 113-139
3. Drut R., Drut R.M., Gomez M.A., et al. Presence of human papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 27 (1998) 530-535
4. Fjaer R.B., Bruu A.L., and Nordbo S.A. Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant 9 (2005) 68-73
5. Mahjoub F., Shahsiah R., Ardalan F.A., et al. Detection of Epstein-Barr virus by chromogenic in situ hybridization in cases of extrahepatic biliary atresia. Diagn Pathol 3 (2008) 19
6. Fischler B., Ehrnst A., Forsgren M., et al. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 27 (1998) 57-64
7. De Tommaso A.M., Andrade P.D., Costa S.C., et al. High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. BMC Infect Dis 5 (2005) 108
8. Tyler K.L., Sokol R.J., Oberhaus S.M., et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 27 (1998) 1475-1482
9. Riepenhoff-Talty M., Gouvea V., Evans M.J., et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174 (1996) 8-15
10. Riepenhoff-Talty M., Schaekel K., Clark H.F., et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 33 (1993) 394-399
11. Allen S.R., Jafri M., Donnelly B., et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol 81 (2007) 1671-1679
12. Harada K., Sato Y., Itatsu K., et al. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 46 (2007) 1146-1154
13. Rotavirus vaccines. Wkly Epidemiol Rec 82 (2007) 285-295
14. Parashar U.D., Alexander J.P., and Glass R.I. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 (2006) 1-13
15. Rodriguez Z.M., Goveia M.G., Stek J.E., et al. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States. Pediatr Infect Dis J 26 (2007) 221-227
16. Vesikari T., Matson D.O., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
17. Vesikari T., Karvonen A., Prymula R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370 (2007) 1757-1763
18. Linhares A.C., Velazquez F.R., Perez-Schael I., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371 (2008) 1181-1189
19. Flores J., Hoshino Y., Boeggeman E., et al. Genetic relatedness among animal rotaviruses. Arch Virol 87 (1986) 273-285
20. In: Knipe D.M., and Howley P.M. (Eds). Field's virology. 4th ed. (2001), Lippincott-Raven, Philadelphia, PA, USA
21. Choi A.H., McNeal M.M., Flint J.A., et al. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine 20 (2002) 1733-1740
22. Choi A.H., Basu M., McNeal M.M., et al. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol 73 (1999) 7574-7581
23. Choi A.H., Basu M., McNeal M.M., et al. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif 38 (2004) 205-216
24. Knowlton D.R., Spector D.M., and Ward R.L. Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods 33 (1991) 127-134
25. McNeal M.M., Broome R.L., and Ward R.L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 204 (1994) 642-650
26. McNeal M.M., Rae M.N., Bean J.A., et al. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol 73 (1999) 7565-7573
27. McNeal M.M., Sheridan J.F., and Ward R.L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 191 (1992) 150-157
28. Offit P.A., and Clark H.F. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol 54 (1985) 58-64
29. Fusaro A.E., Brito C.A., Victor J.R., et al. Maternal-fetal interaction: preconception immunization in mice prevents neonatal sensitization induced by allergen exposure during pregnancy and breastfeeding. Immunology 122 (2007) 107-115
30. VanCott J.L., Prada A.E., McNeal M.M., et al. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. J Virol 80 (2006) 4949-4961
31. Angel J., Franco M.A., and Greenberg H.B. Rotavirus vaccines: recent developments and future considerations. Nat Rev Microbiol 5 (2007) 529-539
32. Mack C.L. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis 27 (2007) 233-242
33. Ward R.L. Rotavirus vaccines: how they work or don't work. Expert Rev Mol Med 10 (2008) e5
34. McLean B., and Holmes I.H. Transfer of antirotaviral antibodies from mothers to their infants. J Clin Microbiol 12 (1980) 320-325
35. Sheridan J.F., Smith C.C., Manak M.M., et al. Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11. J Infect Dis 149 (1984) 434-438
36. Snodgrass D.R., Campbell I., Mwenda J.M., et al. Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination. Vaccine 13 (1995) 408-413
37. Conner M.E., Crawford S.E., Barone C., et al. Rotavirus vaccine administered parenterally induces protective immunity. J Virol 67 (1993) 6633-6641
38. Westerman L.E., Xu J., Jiang B., et al. Experimental infection of pigtailed macaques with a simian rotavirus, YK-1. J Med Virol 75 (2005) 616-625
39. Franco M.A., and Greenberg H.B. Immunity to rotavirus infection in mice. J Infect Dis 179 Suppl 3 (1999) S466-S469
40. Feng N., Lawton J.A., Gilbert J., et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest 109 (2002) 1203-1213
41. Kallewaard N.L., McKinney B.A., Gu Y., et al. Functional maturation of the human antibody response to rotavirus. J Immunol 180 (2008) 3980-3989
42. Kim K.J., Fandy T.E., Lee V.H., et al. Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 287 (2004) L616-L622
43. Rojas R., and Apodaca G. Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol 3 (2002) 944-955
44. Yoshida M., Kobayashi K., Kuo T.T., et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116 (2006) 2142-2151
45. Sokol R.J., Shepherd R.W., Superina R., et al. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 46 (2007) 566-581
46. Zaman K., Roy E., Arifeen S.E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008) 1555-1564